Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial.
Curtis PJ, van der Velpen V, Berends L, Jennings A, Feelisch M, Umpleby AM, Evans M, Fernandez BO, Meiss MS, Minnion M, Potter J, Minihane AM, Kay CD, Rimm EB, Cassidy A. Curtis PJ, et al. Among authors: umpleby am. Am J Clin Nutr. 2019 Jun 1;109(6):1535-1545. doi: 10.1093/ajcn/nqy380. Am J Clin Nutr. 2019. PMID: 31136659 Free PMC article. Clinical Trial.
Validity of triple- and dual-tracer techniques to estimate glucose appearance.
Haidar A, Elleri D, Allen JM, Harris J, Kumareswaran K, Nodale M, Acerini CL, Wilinska ME, Jackson N, Umpleby AM, Evans ML, Dunger DB, Hovorka R. Haidar A, et al. Among authors: umpleby am. Am J Physiol Endocrinol Metab. 2012 Jun 15;302(12):E1493-501. doi: 10.1152/ajpendo.00581.2011. Epub 2012 Mar 27. Am J Physiol Endocrinol Metab. 2012. PMID: 22454288 Free PMC article.
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance.
Regan FM, Williams RM, McDonald A, Umpleby AM, Acerini CL, O'Rahilly S, Hovorka R, Semple RK, Dunger DB. Regan FM, et al. Among authors: umpleby am. J Clin Endocrinol Metab. 2010 May;95(5):2113-22. doi: 10.1210/jc.2009-2088. Epub 2010 Mar 16. J Clin Endocrinol Metab. 2010. PMID: 20233784
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.
Whyte MB, Shojaee-Moradie F, Sharaf SE, Jackson NC, Fielding B, Hovorka R, Mendis J, Russell-Jones D, Umpleby AM. Whyte MB, et al. Among authors: umpleby am. J Clin Endocrinol Metab. 2019 Feb 1;104(2):359-368. doi: 10.1210/jc.2018-01176. J Clin Endocrinol Metab. 2019. PMID: 30215735 Free PMC article. Clinical Trial.
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
Brown E, Wilton MM, Sprung VS, Harrold JA, Halford JCG, Stancak A, Burgess M, Howarth E, Umpleby AM, Kemp GJ, Wilding JP, Cuthbertson DJ. Brown E, et al. Among authors: umpleby am. BMJ Open. 2021 Jul 20;11(7):e045663. doi: 10.1136/bmjopen-2020-045663. BMJ Open. 2021. PMID: 34285005 Free PMC article.
Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome.
Kaur V, Dimitriadis GK, Pérez-Pevida B, Bansi DS, Jayasena C, Bate D, Houghton R, Fielding BA, Balfoussia D, Webber L, Miao Y, Mears F, Jackson N, Coppin L, Perez J, Williams M, Johnson B, Umpleby AM, Randeva HS, Miras AD. Kaur V, et al. Among authors: umpleby am. Metabolism. 2021 Dec;125:154908. doi: 10.1016/j.metabol.2021.154908. Epub 2021 Oct 7. Metabolism. 2021. PMID: 34627875 Clinical Trial.
150 results